Keratins: Biomarkers and modulators of apoptotic and necrotic cell death in the liver

Nam-on Ku, Pavel Strnad, Heike Bantel, M. Bishr Omary

Research output: Contribution to journalReview article

26 Citations (Scopus)

Abstract

Keratins, formerly known as cytokeratins, are the major epithelial-specific subgroup of intermediate filament proteins. Adult hepatocytes express keratin polypeptides 8 and 18 (K8/K18), whereas cholangiocytes express K8/K18 and keratins 7 and 19 (K7/K19). Keratins function primarily to protect hepatocytes from apoptosis and necrosis, which was revealed using several genetic mouse models. This cytoprotective function was further clarified by the identification of natural human keratin variants that are normally silent, but become pathogenic by predisposing their carriers to apoptosis during acute or chronic liver injury mediated by toxins, virus infection, or metabolic stress. During apoptosis, caspases cleave K18 and K19 at conserved aspartates (human K18/K19: 235Val-Glu-Val-Asp) and K18 at a unique aspartate (human K18: 394Asp-Ala-Leu-Asp), with the latter exposed epitope becoming recognized by the M30 antibody in blood and tissues. Additional K18-containing protein backbone epitopes are detected using the M6 and M5 (termed M65) antibodies. Intact K18 and its associated fragments, which are released into blood during apoptosis and necrosis in various diseases, have been analyzed by enzyme-linked immunosorbent assay using the M30/M65 antibodies or their signal ratios. Furthermore, M30/M65 levels have been used as diagnostic and prognostic biomarkers in acute and chronic liver diseases, including nonalcoholic steatohepatitis and acute liver failure. Other keratin biomarkers include K8/K18/K19-related tissue polypeptide antigen, K18-related tissue polypeptide-specific antigen, and K19-related CYFRA-21-1, which have been evaluated mostly in patients with epithelial tumors. Conclusion: Keratins and their fragments are released into blood during liver and other epithelial tissue injury. The epithelial specificity of K18/K19, epitope unmasking upon caspase digestion, keratin abundance, and relative keratin stability render them useful biomarkers for hepatocyte and cholangiocyte apoptosis and necrosis. However, the precise biochemical nature and release mechanism of circulating keratins remain unknown. (Hepatology 2016;64:966-976).

Original languageEnglish
Pages (from-to)966-976
Number of pages11
JournalHepatology
Volume64
Issue number3
DOIs
Publication statusPublished - 2016 Jan 1

Fingerprint

Keratins
Cell Death
Biomarkers
Liver
Apoptosis
Epitopes
Hepatocytes
Necrosis
Caspases
Aspartic Acid
Antibodies
K-18 conjugate
Tissue Polypeptide Antigen
Keratin-8
Keratin-7
Keratin-18
Keratin-19
Intermediate Filament Proteins
Forensic Anthropology
Physiological Stress

All Science Journal Classification (ASJC) codes

  • Hepatology

Cite this

Ku, Nam-on ; Strnad, Pavel ; Bantel, Heike ; Omary, M. Bishr. / Keratins : Biomarkers and modulators of apoptotic and necrotic cell death in the liver. In: Hepatology. 2016 ; Vol. 64, No. 3. pp. 966-976.
@article{e8addb162bae45dcbdff4fc2c2a52c2c,
title = "Keratins: Biomarkers and modulators of apoptotic and necrotic cell death in the liver",
abstract = "Keratins, formerly known as cytokeratins, are the major epithelial-specific subgroup of intermediate filament proteins. Adult hepatocytes express keratin polypeptides 8 and 18 (K8/K18), whereas cholangiocytes express K8/K18 and keratins 7 and 19 (K7/K19). Keratins function primarily to protect hepatocytes from apoptosis and necrosis, which was revealed using several genetic mouse models. This cytoprotective function was further clarified by the identification of natural human keratin variants that are normally silent, but become pathogenic by predisposing their carriers to apoptosis during acute or chronic liver injury mediated by toxins, virus infection, or metabolic stress. During apoptosis, caspases cleave K18 and K19 at conserved aspartates (human K18/K19: 235Val-Glu-Val-Asp↓) and K18 at a unique aspartate (human K18: 394Asp-Ala-Leu-Asp↓), with the latter exposed epitope becoming recognized by the M30 antibody in blood and tissues. Additional K18-containing protein backbone epitopes are detected using the M6 and M5 (termed M65) antibodies. Intact K18 and its associated fragments, which are released into blood during apoptosis and necrosis in various diseases, have been analyzed by enzyme-linked immunosorbent assay using the M30/M65 antibodies or their signal ratios. Furthermore, M30/M65 levels have been used as diagnostic and prognostic biomarkers in acute and chronic liver diseases, including nonalcoholic steatohepatitis and acute liver failure. Other keratin biomarkers include K8/K18/K19-related tissue polypeptide antigen, K18-related tissue polypeptide-specific antigen, and K19-related CYFRA-21-1, which have been evaluated mostly in patients with epithelial tumors. Conclusion: Keratins and their fragments are released into blood during liver and other epithelial tissue injury. The epithelial specificity of K18/K19, epitope unmasking upon caspase digestion, keratin abundance, and relative keratin stability render them useful biomarkers for hepatocyte and cholangiocyte apoptosis and necrosis. However, the precise biochemical nature and release mechanism of circulating keratins remain unknown. (Hepatology 2016;64:966-976).",
author = "Nam-on Ku and Pavel Strnad and Heike Bantel and Omary, {M. Bishr}",
year = "2016",
month = "1",
day = "1",
doi = "10.1002/hep.28493",
language = "English",
volume = "64",
pages = "966--976",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

Keratins : Biomarkers and modulators of apoptotic and necrotic cell death in the liver. / Ku, Nam-on; Strnad, Pavel; Bantel, Heike; Omary, M. Bishr.

In: Hepatology, Vol. 64, No. 3, 01.01.2016, p. 966-976.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Keratins

T2 - Biomarkers and modulators of apoptotic and necrotic cell death in the liver

AU - Ku, Nam-on

AU - Strnad, Pavel

AU - Bantel, Heike

AU - Omary, M. Bishr

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Keratins, formerly known as cytokeratins, are the major epithelial-specific subgroup of intermediate filament proteins. Adult hepatocytes express keratin polypeptides 8 and 18 (K8/K18), whereas cholangiocytes express K8/K18 and keratins 7 and 19 (K7/K19). Keratins function primarily to protect hepatocytes from apoptosis and necrosis, which was revealed using several genetic mouse models. This cytoprotective function was further clarified by the identification of natural human keratin variants that are normally silent, but become pathogenic by predisposing their carriers to apoptosis during acute or chronic liver injury mediated by toxins, virus infection, or metabolic stress. During apoptosis, caspases cleave K18 and K19 at conserved aspartates (human K18/K19: 235Val-Glu-Val-Asp↓) and K18 at a unique aspartate (human K18: 394Asp-Ala-Leu-Asp↓), with the latter exposed epitope becoming recognized by the M30 antibody in blood and tissues. Additional K18-containing protein backbone epitopes are detected using the M6 and M5 (termed M65) antibodies. Intact K18 and its associated fragments, which are released into blood during apoptosis and necrosis in various diseases, have been analyzed by enzyme-linked immunosorbent assay using the M30/M65 antibodies or their signal ratios. Furthermore, M30/M65 levels have been used as diagnostic and prognostic biomarkers in acute and chronic liver diseases, including nonalcoholic steatohepatitis and acute liver failure. Other keratin biomarkers include K8/K18/K19-related tissue polypeptide antigen, K18-related tissue polypeptide-specific antigen, and K19-related CYFRA-21-1, which have been evaluated mostly in patients with epithelial tumors. Conclusion: Keratins and their fragments are released into blood during liver and other epithelial tissue injury. The epithelial specificity of K18/K19, epitope unmasking upon caspase digestion, keratin abundance, and relative keratin stability render them useful biomarkers for hepatocyte and cholangiocyte apoptosis and necrosis. However, the precise biochemical nature and release mechanism of circulating keratins remain unknown. (Hepatology 2016;64:966-976).

AB - Keratins, formerly known as cytokeratins, are the major epithelial-specific subgroup of intermediate filament proteins. Adult hepatocytes express keratin polypeptides 8 and 18 (K8/K18), whereas cholangiocytes express K8/K18 and keratins 7 and 19 (K7/K19). Keratins function primarily to protect hepatocytes from apoptosis and necrosis, which was revealed using several genetic mouse models. This cytoprotective function was further clarified by the identification of natural human keratin variants that are normally silent, but become pathogenic by predisposing their carriers to apoptosis during acute or chronic liver injury mediated by toxins, virus infection, or metabolic stress. During apoptosis, caspases cleave K18 and K19 at conserved aspartates (human K18/K19: 235Val-Glu-Val-Asp↓) and K18 at a unique aspartate (human K18: 394Asp-Ala-Leu-Asp↓), with the latter exposed epitope becoming recognized by the M30 antibody in blood and tissues. Additional K18-containing protein backbone epitopes are detected using the M6 and M5 (termed M65) antibodies. Intact K18 and its associated fragments, which are released into blood during apoptosis and necrosis in various diseases, have been analyzed by enzyme-linked immunosorbent assay using the M30/M65 antibodies or their signal ratios. Furthermore, M30/M65 levels have been used as diagnostic and prognostic biomarkers in acute and chronic liver diseases, including nonalcoholic steatohepatitis and acute liver failure. Other keratin biomarkers include K8/K18/K19-related tissue polypeptide antigen, K18-related tissue polypeptide-specific antigen, and K19-related CYFRA-21-1, which have been evaluated mostly in patients with epithelial tumors. Conclusion: Keratins and their fragments are released into blood during liver and other epithelial tissue injury. The epithelial specificity of K18/K19, epitope unmasking upon caspase digestion, keratin abundance, and relative keratin stability render them useful biomarkers for hepatocyte and cholangiocyte apoptosis and necrosis. However, the precise biochemical nature and release mechanism of circulating keratins remain unknown. (Hepatology 2016;64:966-976).

UR - http://www.scopus.com/inward/record.url?scp=84987856185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84987856185&partnerID=8YFLogxK

U2 - 10.1002/hep.28493

DO - 10.1002/hep.28493

M3 - Review article

C2 - 26853542

AN - SCOPUS:84987856185

VL - 64

SP - 966

EP - 976

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 3

ER -